Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

2.

HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?

März W, Wieland H.

Herz. 2000 Mar;25(2):117-25. Review.

PMID:
10829251
4.

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

Rosenson RS.

Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.

PMID:
14728000
5.

Lipid and non-lipid effects of statins.

Paoletti R, Bolego C, Cignarella A.

Handb Exp Pharmacol. 2005;(170):365-88. Review.

PMID:
16596807
6.
7.

HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?

März W, Köenig W.

J Cardiovasc Risk. 2003 Jun;10(3):169-79. Review.

PMID:
12775949
8.

Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis.

Genser B, Grammer TB, Stojakovic T, Siekmeier R, März W.

Int J Clin Pharmacol Ther. 2008 Oct;46(10):497-510. Review.

PMID:
18826864
9.

Statins for treatment of dyslipidemia in chronic kidney disease.

Shurraw S, Tonelli M.

Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.

PMID:
16973506
10.
11.

Statins: potent vascular anti-inflammatory agents.

Liao JK.

Int J Clin Pract Suppl. 2004 Oct;(143):41-8. Review.

PMID:
16035395
12.

Pleiotropic effects of HMG-CoA reductase inhibitors.

Bocan TM.

Curr Opin Investig Drugs. 2002 Sep;3(9):1312-7. Review.

PMID:
12498006
13.

[Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].

Hanss R, Bein B.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2010 Apr;45(4):246-52; quiz 253. doi: 10.1055/s-0030-1253093. Epub 2010 Apr 12. Review. German.

PMID:
20387182
14.

Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.

Marzilli M.

Am J Cardiovasc Drugs. 2010;10 Suppl 1:3-9. doi: 10.2165/1153644-S0-000000000-00000. Review.

PMID:
21391728
15.

Statins: a treatment option for chronic heart failure?

von Haehling S, Okonko DO, Anker SD.

Heart Fail Monit. 2004;4(3):90-7. Review.

PMID:
15772704
16.
18.

Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.

Miida T, Hirayama S, Nakamura Y.

J Atheroscler Thromb. 2004;11(5):253-64. Review.

19.

Statin therapy in heart failure.

Pham M, Oka RK, Giacomini JC.

Curr Opin Lipidol. 2005 Dec;16(6):630-4. Review.

PMID:
16276240
20.

Beyond the laboratory: clinical implications for statin pleiotropy.

Halcox JP, Deanfield JE.

Circulation. 2004 Jun 1;109(21 Suppl 1):II42-8. Review.

Supplemental Content

Support Center